Oncolytics Biotech (ONCY) Return on Equity [ROE] (2011 - 2025)
Oncolytics Biotech (ONCY) reported Return on Equity [ROE] of -1333.24% for Q3 2025, down 1130.34 percentage points from -202.91% a year earlier and down 801.97 percentage points from the prior quarter.
Powered by 
Analysis
Oncolytics Biotech (ONCY) Return on Equity [ROE] (2011 - 2025) Analysis & Trends
For FY2024, Oncolytics Biotech posted Return on Equity [ROE] of -192.66%, down 91.44 percentage points from FY2023.
- Return on Equity [ROE] has a five-year change of +869.04 percentage points (FY2019 to FY2024).
- By year, Return on Equity [ROE] came in at -101.22% in FY2023 (-24.41 pp), -76.81% in FY2022 (+12.01 pp), -88.82% in FY2021 (+93.82 pp) and -182.64% in FY2020 (+879.07 pp).
- The Q3 2025 figure ranks as the lowest quarterly Return on Equity [ROE] in data going back to Q1 2009.
- Year over year, Return on Equity [ROE] has now declined in each of the last seven quarters, with an average year-over-year change of -293.92 percentage points over the last eight quarters.
- The high point for year-over-year Return on Equity [ROE] in five years was Q4 2021 (a gain of 29.98 percentage points); the low point was Q3 2025 (a drop of 1130.34 percentage points).
- Per Business Quant data, the three quarters before Q3 2025 came in at -531.27% (Q2 2025), -510.72% (Q1 2025) and -418.49% (Q4 2024).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,171.69 Bn | 1,140.28 Bn | 19.71 Bn | 82.09% |
| 2 | Johnson & Johnson | 649.22 Bn | 569.08 Bn | 17.30 Bn | 19.33% |
| 3 | AbbVie | 504.17 Bn | 477.29 Bn | 12.70 Bn | - |
| 4 | Merck | 366.35 Bn | 320.73 Bn | 12.21 Bn | 7.21% |
| 5 | Novartis Ag | 303.54 Bn | 267.53 Bn | 11.24 Bn | 31.52% |
| 6 | Astrazeneca | 269.49 Bn | 243.18 Bn | 12.86 Bn | 21.39% |
| 7 | Amgen | 242.61 Bn | 198.01 Bn | 7.24 Bn | 83.75% |
| 8 | Gilead Sciences | 195.09 Bn | 169.29 Bn | 6.22 Bn | -18.38% |
| 9 | Pfizer | 172.48 Bn | 119.12 Bn | 10.94 Bn | 4.97% |
| 10 | Oncolytics Biotech | 60.12 Mn | 31.24 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | -1,333.57% |
| Dec 31, 2024 | -456.97% |
| Sep 30, 2024 | -202.46% |
| Jun 30, 2024 | -136.24% |
| Sep 30, 2023 | -125.21% |
| Jun 30, 2023 | -111.40% |
| Mar 31, 2023 | -102.51% |
| Dec 31, 2022 | -104.67% |
| Sep 30, 2022 | -83.38% |
| Jun 30, 2022 | -81.38% |
| Dec 31, 2021 | -67.79% |
| Sep 30, 2021 | -62.05% |
| Jun 30, 2021 | -63.74% |
| Mar 31, 2021 | -81.23% |
| Dec 31, 2020 | -82.34% |
| Sep 30, 2020 | -57.82% |
| Jun 30, 2020 | -55.62% |
| Mar 31, 2020 | -113.09% |
| Sep 30, 2019 | -284.74% |
| Jun 30, 2019 | -54.10% |
API Access
Oncolytics Biotech Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=ONCY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "ONCY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=ONCY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();